K243854 is an FDA 510(k) clearance for the Contour Light (CL-100). Classified as Fat Reducing Low Level Laser within the OLI classification (a category for non-invasive low-level laser body contouring systems), Class II - Special Controls.
Submitted by Contour Research, LLC (Reno, US). The FDA issued a Cleared decision on February 13, 2026 after a review of 424 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.5400 - the FDA general and plastic surgery device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General & Plastic Surgery submissions.
View all Contour Research, LLC devices
NCT04451824
Completed
Interventional
Industry-sponsored
Examination of Circumferential Reduction
Contour Research CL-100 Examination of Circumferential Reduction: A Review of Data Collected From Routine Use of the Device
| Condition studied |
Overweight or Obesity |
| Study design |
Single group |
| Eligibility |
All sexes
· 18 Years+
· Healthy volunteers accepted
|
| Principal investigator |
Doug Dreier, BS |
| Sponsor |
Contour Research
(industry)
|
Started 2018-09-01
→
Primary completion 2018-11-30
→
Completed 2018-12-31
Primary outcome
Examination of Circumferential Reduction - Primary Objective
Secondary outcome
Examination of Circumferential Reduction - Secondary Objective
Study completed - no results published.
This trial concluded in 2018 but has not posted
results to ClinicalTrials.gov. Completed studies without public results are common
in industry-sponsored device trials; the data may be referenced in the
510(k) Summary PDF or remain unpublished.
Individual participant data will not be shared.
View full study on ClinicalTrials.gov